在Hydroxyurea药理学中OCT1和MAP3K5遗传多态的作用
Sarah Allegra1, Giuliana Abbadessa1, Francesco Chiara1,2
1Clinical Pharmacology, Department of Clinical and Biological Sciences, University of Turin, Orbassano, 10043 Turin, Italy.
Life (Basel, Switzerland)
|August 28, 2025
概括
在状细胞病患者中,OCT1的遗传变异会影响基尿素的半衰期. 这种药物遗传洞察力,考虑到性别和种族,可以个性化治疗以获得更好的结果.
科学领域:
- 药物遗传学
- 基因组学
- 血液学
背景情况:
- 氨酸是状细胞疾病的标准治疗方法,但其疗效在个体之间有很大差异.
- 这种变化需要更高的剂量,并可能导致毒性增加.
- 了解遗传因素是个性化尿素治疗的关键.
研究的目的:
- 研究OCT1和MAP3K5基因多态对基尿素药理学的影响.
- 探索这些遗传影响的潜在种族和性别差异.
主要方法:
- 79名状细胞病患者的回顾性分析.
- OCT1 (rs683369) 和MAP3K5 (rs9376230,rs9483947) 多态体的基因定型
主要成果:
- 与GC基因型相比,在撒哈拉以南地区的患者中,OCT1 rs683369 GG基因型的半衰期较短.
- 在撒哈拉以南地区的女性儿科患者中也观察到这种关联.
结论:
- 基因变异,特别是OCT1多态性,显著影响基尿素的药理学.
- 考虑性别和种族对于基尿素的药物遗传学研究至关重要.
- 这些发现突显了药物遗传学在状细胞病的临床管理方面有潜力.
相关概念视频
Nonlinear Pharmacokinetics: Role of Transporters
91
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
91
Hepatic Drug Excretion: Influencing Factors
214
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
214
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
293
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
293
Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa
267
The pH of urine, the drug's pKa, and the urine flow rate are vital parameters for drug reabsorption and excretion. Urinary pH varies between 4.6 and 8.0 and is influenced by diet, drug intake, and the patient's pathophysiology. It affects a drug's ionization state and reabsorption. For instance, carbohydrate-rich food produces alkaline urine promoting drug excretion, while proteins and certain medications like ascorbic acid lead to acidic urine enhancing reabsorption.
The pKa of a...
The pKa of a...
267
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
312
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
312
Hepatic Drug Clearance: Role of Transporters
100
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
100


